Boston Scientific entered into a deal to acquire Baylis Medical, a medical devices maker with headquarters in Canada, for an upfront payment of $1.75 billion in a bid to expand the Mass.-based company’s electrophysiology and structural heart product portfolio. 

In this webinar, you will hear from the Kline Group about a trend moving into dietary supplements, and from Catalent about how supplement brands are accelerating toward a more natural, plant–based portfolio, including in the ever–important heart health market.

When it comes to matters of heart health, no amount of exercise is too much, scientists said regarding research that debunks the myth that high levels of vigorous physical activity might not always be beneficial.

Kate Cronin, Global CEO of Ogilvy Health, shares her views on a variety of healthcare industry topics in a Q&A with PharmaLive.

Apple Inc. launched an app that will let users of the company’s devices to enroll in three health studies, allowing them to share health-related data for medical research.

Early detection of cardiovascular disease is becoming possible due to research from Giovanna Guidoboni, Marjorie Skubic and a team at the University of Missouri.